Company · CIK 0001403752 · SIC 2834 — Pharmaceutical Preparations
Zymeworks Inc. · ZYME
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2019 SForm 4 → | Feb 4, 4:36 pm EST | LILLY ELI & CO10% Owner | 250,000 | $16.00 | $4,000,000 | 2,898,647 | −7.94% | plan? amended |
| Jan 8, 2019 AForm 4 → | Jan 10, 5:55 pm EST | Diana HausmanChief Medical Officer | 499 | $12.48 | $6,228 | 2,499 | — | plan? |
| Jan 8, 2019 AForm 4 → | Jan 10, 5:49 pm EST | Neil A KlompasChief Financial Officer | 414 | $12.48 | $5,167 | 1,201 | — | plan? |
| Nov 6, 2018 SForm 4 → | Nov 8, 11:34 am EST | LILLY ELI & CO10% Owner | 700,000 | $14.00 | $9,800,000 | 3,148,647 | −18.2% | plan? |
| Sep 24, 2018 SForm 4 → | Sep 26, 2:50 pm EDT | LILLY ELI & CO10% Owner | 2,027 | $16.36 | $33,162 | 3,848,647 | −0.05% | plan? |
| Sep 18, 2018 SForm 4 → | Sep 20, 4:50 pm EDT | LILLY ELI & CO10% Owner | 6,870 | $14.56 | $100,027 | 3,850,674 | −0.18% | plan? |
| Sep 14, 2018 SForm 4 → | Sep 18, 7:30 pm EDT | LILLY ELI & CO10% Owner | 15,874 | $14.58 | $231,443 | 3,857,544 | −0.41% | plan? |
| Sep 12, 2018 SForm 4 → | Sep 14, 3:34 pm EDT | LILLY ELI & CO10% Owner | 30,959 | $14.49 | $448,463 | 3,873,418 | −0.79% | plan? |
| Sep 10, 2018 SForm 4 → | Sep 12, 4:39 pm EDT | LILLY ELI & CO10% Owner | 15,777 | $14.75 | $232,669 | 3,904,377 | −0.40% | plan? |
| Aug 31, 2018 SForm 4 → | Sep 4, 3:38 pm EDT | LILLY ELI & CO10% Owner | 700 | $14.26 | $9,982 | 3,920,154 | −0.02% | plan? |
| Aug 29, 2018 SForm 4 → | Aug 31, 12:40 pm EDT | LILLY ELI & CO10% Owner | 5,752 | $14.31 | $82,333 | 3,920,854 | −0.15% | plan? |
| Aug 14, 2018 SForm 4 → | Aug 16, 3:34 pm EDT | LILLY ELI & CO10% Owner | 3,000 | $14.28 | $42,840 | 3,926,606 | −0.08% | plan? |
| Aug 10, 2018 SForm 4 → | Aug 14, 5:04 pm EDT | LILLY ELI & CO10% Owner | 6,429 | $14.32 | $92,033 | 3,929,606 | −0.16% | plan? |
| Aug 3, 2018 SForm 4 → | Aug 7, 3:16 pm EDT | LILLY ELI & CO10% Owner | 1,650 | $13.55 | $22,358 | 3,936,035 | −0.04% | plan? |
| Aug 2, 2018 SForm 4 → | Aug 3, 3:53 pm EDT | LILLY ELI & CO10% Owner | 19,400 | $13.31 | $258,214 | 3,937,685 | −0.49% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2019 AForm 4 → | Jan 10, 5:55 pm EST | Diana HausmanChief Medical Officer | 75,000 | — | — | 75,000 | — | |
| Jan 8, 2019 AForm 4 → | Jan 10, 5:49 pm EST | Neil A KlompasChief Financial Officer | 90,000 | — | — | 90,000 | — | |
| Jan 8, 2019 AForm 4 → | Jan 10, 4:26 pm EST | Ali TehraniChief Executive Officer, Director | 235,000 | — | — | 235,000 | — | |
| Jan 8, 2019 AForm 4 → | Jan 10, 4:23 pm EST | Anthony J. PolverinoChief Scientific Officer | 75,000 | — | — | 75,000 | — | |
| Jan 8, 2019 AForm 4 → | Jan 10, 4:22 pm EST | David Kai Yuen PoonSee Remarks | 25,000 | — | — | 25,000 | — |